Your search returned 3 results.

Results
	1.	Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy. [electronic resource] by Patel, Hitendra Stoller, Ronald Auber, Miklos Potter, Douglas Cai, Chao Zamboni, William Kiefer, Gauri Matin, Khalid Schmotzer, Amy Ramanathan, Ramesh K Producer: 20070323 In: Investigational new drugs vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer. [electronic resource] by Brell, Joanna M Matin, Khalid Evans, Terry Volkin, Robert L Kiefer, Gauri J Schlesselman, James J Dranko, Shelley Rath, Linda Schmotzer, Amy Lenzner, Diana Ramanathan, Ramesh K Producer: 20090407 In: Oncology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. [electronic resource] by Lo, Shelly S Khorana, Alok A Javle, Milind Simon, Sheryl Kiefer, Gauri Rajasenan, Kiran Wang, Hong Hantel, Alexander Shayne, Michelle Hwang, Jimmy Schmotzer, Amy Ramanathan, Ramesh K Producer: 20100528 In: Oncology vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)